Search Results

599 Highly-effective CFTR modulator therapy with elexacaftor-tezacaftorivacaftor leads to age-dependent changes in cystic fibrosis microbiology—data from the German cystic fibrosis registry.

• Authors : Dittrich, A. (AUTHOR); Sieber, S. (AUTHOR); Naehrlich, L. (AUTHOR)

Subjects: *CYSTIC fibrosis; *CYSTIC fibrosis transmembrane conductance regulator; *MICROBIOLOGY

• Source: Journal of Cystic Fibrosis. 2023 Supplement 3, Vol. 22, pS318-S318. 1p.

Record details

Cystic fibrosis microbiology: Advances in antimicrobial therapy.

• Authors : Waters, Valerie¹ ; Smyth, Alan²

Subjects: *CYSTIC fibrosis; *ANTI-infective agents; *MICROBIOLOGY

• Source: Journal of Cystic Fibrosis. Sep2015, Vol. 14 Issue 5, p551-560. 10p.

Record details

Practical Laboratory Aspects of Cystic Fibrosis Microbiology: an Update, Part II

• Authors : Kiska, Deanna L. ; Riddell, Scott W.¹

Subjects: *CYSTIC fibrosis; *DIAGNOSTIC microbiology; *PATHOGENIC microorganisms

• Source: Clinical Microbiology Newsletter. Mar2012, Vol. 34 Issue 5, p35-41. 7p.

Record details

Practical Laboratory Aspects of Cystic Fibrosis Microbiology: an Update, Part I

• Authors : Kiska, Deanna L. ; Riddell, Scott W.¹

Subjects: *CYSTIC fibrosis; *MEDICAL microbiology; *PATHOLOGICAL laboratories

• Source: Clinical Microbiology Newsletter. Feb2012, Vol. 34 Issue 4, p27-31. 5p.

Record details

Insights into cystic fibrosis microbiology from the European tobramycin trial in cystic fibrosis

• Authors : Govan, J.R.W.¹

Subjects: *CYSTIC fibrosis; *PSEUDOMONAS aeruginosa; *BIOFILMS

• Source: Journal of Cystic Fibrosis. Dec2002, Vol. 1 Issue 5, p203. 6p.

Record details

117 Results of an on-line survey of cystic fibrosis microbiology practices in UK laboratories

• Authors : Denton, M.; Doherty, C.; Foweraker, J.

• Source: Journal of Cystic Fibrosis. Jun2011 Supplement 1, Vol. 10, pS30-S30. 1p.

Record details

Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trials.

• Authors : Weiser, Rebecca¹ (AUTHOR) ; Rye, Philip D.² (AUTHOR) ; Mahenthiralingam, Eshwar¹ (AUTHOR)

Subjects: *BURKHOLDERIA infections; *PSEUDOMONAS aeruginosa infections; *LUNG infections

• Source: Journal of Microbiological Methods. Feb2021, Vol. 181, pN.PAG-N.PAG. 1p.

Record details

Sexual dimorphism in the microbiology of the CF 'Gender Gap': Estrogen modulation of Pseudomonas aeruginosa virulence.

• Authors : Tyrrell, Jean^1,2 (AUTHOR); Harvey, Brian J.^1,3 (AUTHOR)

Subjects: *ACHROMOBACTER; *SEXUAL dimorphism; *PSEUDOMONAS aeruginosa

• Source: Steroids. Apr2020, Vol. 156, pN.PAG-N.PAG. 1p.

Record details

Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis.

• Authors : Parize, Perrine^1,2 ; Billaud, Sandrine³; Bienvenu, Anne L.^4,5

Subjects: *CYSTIC fibrosis; *SEROPREVALENCE; *ASPERGILLUS fumigatus

• Source: Journal of Cystic Fibrosis. Dec2014, Vol. 13 Issue 6, p667-673. 7p.

Record details

Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients.

• Authors : de Vrankrijker, A. M. M.¹ ; Brimicombe, R. W.²; Wolfs, T. F. W.³

Subjects: *PSEUDOMONAS aeruginosa; *CYSTIC fibrosis; *ANTIBIOTICSNETHERLANDS

• Source: Clinical Microbiology & Infection. Mar2011, Vol. 17 Issue 3, p382-385. 4p.

Record details